{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-035999","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2026-08-04T20:15:18+00:00","discovered_at":"2026-08-04T20:17:00.424402+00:00","generated_at":"2026-08-04T20:18:09.868998+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Oncotelic Therapeutics issues $178,410 convertible note to Pacific Pier Capital with 500,000 commitment shares","bullets":["Gross principal $178,410; net proceeds ~$150,000 after 12% OID and $7,000 legal fee.","Note convertible at $0.06/share or 85% of lowest traded price in prior 10 trading days.","500,000 commitment shares of common stock issued to Pacific Pier as additional consideration.","Matures one year from August 3, 2026; 12% interest; 12% original issue discount.","Prepayment allowed within first six months with three trading days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-035999","json":"https://secwatch.observer/filing/0001493152-26-035999.json","markdown":"https://secwatch.observer/filing/0001493152-26-035999.md","text":"https://secwatch.observer/filing/0001493152-26-035999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/0001493152-26-035999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:18:09.868998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}